Xr Securities LLC Biogen Inc. Put Options Transaction History

Xr Securities LLC

$5.35 Billion
Q4 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $275,626 - $348,023	-1,300 Reduced 34.21%	2,500 $539,000
Q4 2023 Feb 02, 2024	BUY	$222.59 - $267.94 $44,518 - $53,588	200 Added 5.56%	3,800 $983,000
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $329,290 - $371,657	-1,300 Reduced 26.53%	3,600 $925,000
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $467,925 - $540,702	1,700 Added 53.13%	4,900 $1.4 Million
Q1 2023 May 02, 2023	SELL	$256.56 - $292.34 $1.31 Million - $1.49 Million	-5,100 Reduced 61.45%	3,200 $889,000
Q4 2022 Jan 23, 2023	BUY	$252.44 - $306.72 $2.1 Million - $2.55 Million	8,300 New	8,300 $0
Q2 2022 Jul 14, 2022	BUY	$187.54 - $223.02 $243,802 - $289,926	1,300 Added 28.89%	5,800 $207,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $1.1 Million - $1.39 Million	-5,700 Reduced 55.88%	4,500 $200,000
Q4 2021 Jan 10, 2022	BUY	$223.92 - $287.77 $2.28 Million - $2.94 Million	10,200 New	10,200 $304,000
Q3 2021 Oct 14, 2021	SELL	$282.99 - $369.05 $1.73 Million - $2.25 Million	-6,100 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $932,400 - $1.49 Million	-3,600 Reduced 37.11%	6,100 $227,000
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $97,180 - $113,852	400 Added 4.3%	9,700 $204,000
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $2.2 Million - $3.31 Million	9,300 New	9,300 $301,000
Q3 2020 Oct 28, 2020	SELL	$264.77 - $305.71 $1.88 Million - $2.17 Million	-7,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $1.84 Million - $2.43 Million	7,100 New	7,100 $244,000
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $5.97 Million - $7.57 Million	-22,200 Closed	0 $0
Q4 2019 Jan 06, 2020	SELL	$220.06 - $304.07 $286,078 - $395,291	-1,300 Reduced 5.53%	22,200 $53,000
Q3 2019 Oct 03, 2019	BUY	$217.44 - $243.88 $761,040 - $853,580	3,500 Added 17.5%	23,500 $274,000
Q2 2019 Jul 10, 2019	BUY	$219.29 - $241.72 $1.71 Million - $1.89 Million	7,800 Added 63.93%	20,000 $290,000
Q4 2018 Jan 03, 2019	BUY	$278.5 - $352.75 $3.4 Million - $4.3 Million	12,200 New	12,200 $349,000

Others Institutions Holding BIIB

# of Institutions

992

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Account